Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Glaucoma research
Cornea imaging
Retina surgery
 
 
Survey

Do you use ocriplasmin to treat VMT in your practice?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


March 19, 2014
Risk factor for NTG
Sleep apnoea is risk factor for NTG
Obstructive sleep apnoea syndrome is a significant risk factor for normal-tension glaucoma (NTG), according to a newly published research article. More...
Corneal topography map
Post-op topography map predicts high curvature gradients
When predicting topographical change in corneal remodelling, the new curvature gradient map, acquired immediately after surgery, predicted change in tangential curvature over the subsequent 12 months in areas where initial tangential curvature was greatest. More...
Treating retinal detachment
Urgent surgery for RD gives best post-op VA
Urgent vitrectomy/phacovitrectomy to treat retinal detachment will produce the best postoperative visual acuity when it is conducted within 2 days or less of the detachment (RD), according to a recent study. More...
Event Profile
120th Congress of the French Society of Ophthalmology
Dates: 10–13 May 2014
Venue: Palais des Congrès, Porte Maillot, Paris
The SFO’s annual congress will bring together more than 8000 attendees, 100 exhibitors, 60 scientific sessions, 300 oral communications, 60 workshops, symposia with foreign Societies, 450 e-posters and e-films … Hot Topics will be discussed, a live surgery session on Monday 12th will be programmed, and a specific space (2nd floor) will be dedicated to technology and communication.
Read more:
Ranibizumab leading the anti-VEGF evolution
Considerations and new perspectives in anti-VEGF therapy. Read more:
Choosing and using the AcrySof IQ ReSTOR IOL family
Customize
d options for individual patients. Read more:
The Safety of anti-VEGF Therapy
Under the microscope, in trials and in clinical practice. Read more: